CN101166706A - 氢醌长链衍生物和/或苯氧基长链衍生物及含有它们的药品 - Google Patents
氢醌长链衍生物和/或苯氧基长链衍生物及含有它们的药品 Download PDFInfo
- Publication number
- CN101166706A CN101166706A CNA2006800141431A CN200680014143A CN101166706A CN 101166706 A CN101166706 A CN 101166706A CN A2006800141431 A CNA2006800141431 A CN A2006800141431A CN 200680014143 A CN200680014143 A CN 200680014143A CN 101166706 A CN101166706 A CN 101166706A
- Authority
- CN
- China
- Prior art keywords
- hydrate
- solvate
- nervous system
- compound
- dysfunction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
- C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
- C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with no unsaturation outside the aromatic ring
- C07C39/08—Dihydroxy benzenes; Alkylated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with no unsaturation outside the aromatic ring
- C07C39/11—Alkylated hydroxy benzenes containing also acyclically bound hydroxy groups, e.g. saligenol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/205—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
- C07C43/2055—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring containing more than one ether bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
Abstract
Description
[a]HBr 57%、环己烷、回流、6小时;[b] 1)NaN、THF、室温、30分钟,2)BnBr、THF、回流、24小时;[c]乙炔锂-二胺络合物、DMSO、0℃至室温、12小时;[d]2,5-二甲氧基-1-溴代苯、Pd(PPh3)4、哌啶、80℃、6小时;[e]Pd/C5%、H2、EtOH、一昼夜。 |
[a]HBr 57%、环己烷、回流、6小时;[b] 1)NaN、THF、室温、30分钟,2)BnBr、THF、回流、24小时;[c]乙炔锂-二胺络合物、DMSO、0℃至室温、12小时;[d]2,4,5-三甲氧基-1-溴代苯、Pd(PPh3)4、哌啶、80℃、24小时;[e]Pd/C5%、H2、EtOH、一昼夜。 |
[a]HBr 57%、环己烷、回流、6小时;[b]TBDMSCl、咪唑、CH2Cl2、室温、4小时;[c]2,5-二甲氧基苯胺、THF、二噁烷、0℃~60℃、24小时;[d]TBAF、THF、室温、一昼夜。 |
[a]HBr 57%、环己烷、回流、6小时;[b]1)mCPBA、CH2Cl2、24小时,2)NaOH 10%;[c]2,5-二甲氧基苯酚、丙酮、回流、24小时。 |
合成实施例 | 5 | 6 | 7 | 8 | 9 | 13 | 14 | 15 | 16 | 17 |
R1 | Me | Me | Me | Me | Me | Me | Me | Me | Me | Me |
R2 | H | H | H | H | H | MeO | MeO | MeO | MeO | MeO |
R3 | H | H | H | H | H | H | H | H | H | H |
R4 | Me | Me | Me | Me | Me | Me | Me | Me | Me | Me |
R5 | H | H | H | H | H | H | H | H | H | H |
X | 12 | 14 | 15 | 16 | 18 | 14 | 12 | 15 | 16 | 18 |
DPPH试验 | - | - | - | - | - | - | - | - | - | - |
OH试验 | - | - | - | - | - | ++ | ++ | ++ | ++ | ++ |
合成实施例 | 21 | 22 | 23 | 24 | 29 | 30 | 31 | 32 | 33 | 34 |
R6 | Me | Me | Me | Me | Me | Me | H | H | H | H |
R7 | H | H | H | H | H | H | H | H | H | H |
R8 | H | H | H | H | H | H | H | H | H | H |
R9 | Me | Me | Me | Me | Me | Me | H | H | H | H |
R10 | H | H | H | H | H | H | H | H | H | H |
A | N | N | N | N | O | O | 无 | 无 | 无 | 无 |
Y | 16 | 14 | 12 | 10 | 12 | 16 | 12 | 18 | 16 | 15 |
Z | OH | OH | OH | OH | OH | OH | OH | OH | H | OH |
DPPH试验 | - | - | - | - | - | - | ++ | ++ | + | ++ |
OH试验 | - | - | - | - | - | - | ++ | ++ | + | ++ |
Claims (26)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP054012/2005 | 2005-02-28 | ||
JP2005054012 | 2005-02-28 | ||
PCT/JP2006/303272 WO2006093014A1 (ja) | 2005-02-28 | 2006-02-23 | ハイドロキノン長鎖誘導体及び/又はフェノキシ長鎖誘導体及びこれらを含有する医薬 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101166706A true CN101166706A (zh) | 2008-04-23 |
CN101166706B CN101166706B (zh) | 2011-08-24 |
Family
ID=36941048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800141431A Expired - Fee Related CN101166706B (zh) | 2005-02-28 | 2006-02-23 | 氢醌长链衍生物和/或苯氧基长链衍生物及含有它们的药品 |
Country Status (7)
Country | Link |
---|---|
US (1) | US7893304B2 (zh) |
EP (2) | EP1854777A4 (zh) |
JP (1) | JP5150807B2 (zh) |
KR (1) | KR101270841B1 (zh) |
CN (1) | CN101166706B (zh) |
CA (1) | CA2599331A1 (zh) |
WO (1) | WO2006093014A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006130775A2 (en) * | 2005-06-01 | 2006-12-07 | Edison Pharmaceuticals, Inc. | Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomakers |
EA019675B1 (ru) * | 2006-02-22 | 2014-05-30 | Эдисон Фармасьютикалз, Инк. | Редокс-активные терапевтические средства для лечения митохондриальных заболеваний и модуляции биомаркера коэнзима q |
WO2010030607A1 (en) | 2008-09-10 | 2010-03-18 | Edison Pharmaceuticals, Inc. | Treatment of pervasive developmental disorders with redox-active therapeutics |
LU91562B1 (en) * | 2009-05-04 | 2010-11-05 | Axoglia Therapeutics S A | Hydroquinone derivatives. |
CA2892084C (en) * | 2012-11-21 | 2020-11-10 | Golden Biotechnology Corporation | Methods and compositions for treating neurodegenerative diseases |
KR20160081086A (ko) | 2014-12-30 | 2016-07-08 | 사단법인 원주옻산업명품화사업단 | 옻 산지 판별방법 |
KR20160081083A (ko) | 2014-12-30 | 2016-07-08 | 사단법인 원주옻산업명품화사업단 | 옻 추출물로부터 분리된 신규한 히드로퀴논 화합물을 함유하는 항산화 또는 세포보호 조성물 |
AU2016369616B2 (en) | 2015-12-17 | 2021-03-25 | Ptc Therapeutics, Inc. | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2246528A1 (en) * | 1973-10-04 | 1975-05-02 | Roussel Uclaf | Di-substd hydroquinone and esterified derivs as antioxidants - esp for use in cosmetic prepns to reduce skin aging |
US4271083A (en) * | 1974-05-02 | 1981-06-02 | Takeda Chemical Industries, Ltd. | 6-Hydroxy-1,4-benzoquinone compounds |
JPS6027009B2 (ja) | 1976-04-21 | 1985-06-26 | オリエンタル写真工業株式会社 | カラ−写真感光材料の製造法 |
JPS5346029A (en) | 1976-10-08 | 1978-04-25 | Konishiroku Photo Ind Co Ltd | Silver halide photographic material |
JPS567737A (en) | 1979-07-02 | 1981-01-27 | Takeda Chem Ind Ltd | Physiologically active quinone and its preparation |
US4252951A (en) * | 1979-10-09 | 1981-02-24 | Eli Lilly And Company | Isolation of syn-7-(2-amino-4-thiazolyl)-(methoxyimino)acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid |
JPS6140236A (ja) * | 1984-08-02 | 1986-02-26 | Yamanouchi Pharmaceut Co Ltd | ハイドロキノン誘導体 |
US5017572A (en) | 1988-04-22 | 1991-05-21 | Delalande S.A. | Derivatives of 1-[3-(4-hydroxyphenyl) 1-hydroxy 1-propyl] benzene substituted in position 2 by an aminoalkyleneoxy chain, the method of preparing same and the application thereof to therapeutics |
JPH02101036A (ja) | 1988-10-05 | 1990-04-12 | Yamanouchi Pharmaceut Co Ltd | アルキルベンゼン誘導体及びその医薬 |
JP2524523B2 (ja) | 1989-02-06 | 1996-08-14 | 富士写真フイルム株式会社 | 画像記録方法 |
JPH08768B2 (ja) * | 1989-08-24 | 1996-01-10 | 武田薬品工業株式会社 | 神経成長因子分泌誘導剤 |
EP0515684A4 (en) | 1990-02-14 | 1993-04-21 | Chugai Seiyaku Kabushiki Kaisha | Inhibitor of denatured ldl formation |
JPH04145036A (ja) | 1990-10-06 | 1992-05-19 | Nippon Suisan Kaisha Ltd | 新規フェノール誘導体 |
JPH04182446A (ja) | 1990-11-15 | 1992-06-30 | Otsuka Pharmaceut Co Ltd | ベンゼン誘導体 |
JPH07110812B2 (ja) | 1990-12-11 | 1995-11-29 | 財団法人喫煙科学研究財団 | 神経成長因子生合成促進剤 |
WO1993002031A1 (en) | 1991-07-24 | 1993-02-04 | Nippon Suisan Kaisha, Ltd. | Alkylphenol derivative |
JPH06140236A (ja) * | 1992-10-27 | 1994-05-20 | Matsushita Electric Works Ltd | 電磁継電器 |
WO1999008987A1 (en) * | 1997-08-13 | 1999-02-25 | Meiji Milk Products Co., Ltd. | Cyclohexenone long-chain alcohol and medicament containing same |
SE9901884D0 (sv) | 1999-05-21 | 1999-05-21 | Pharmacia & Upjohn Ab | Novel compounds their use and preparation |
TWI282356B (en) * | 2003-04-18 | 2007-06-11 | Hitachi Chemical Co Ltd | Polyquinoline copolymer having branch structure and organic electroluminescence element using the same |
-
2006
- 2006-02-23 JP JP2007505874A patent/JP5150807B2/ja not_active Expired - Fee Related
- 2006-02-23 WO PCT/JP2006/303272 patent/WO2006093014A1/ja active Application Filing
- 2006-02-23 CA CA002599331A patent/CA2599331A1/en not_active Abandoned
- 2006-02-23 EP EP06714412A patent/EP1854777A4/en not_active Withdrawn
- 2006-02-23 KR KR1020077022046A patent/KR101270841B1/ko not_active IP Right Cessation
- 2006-02-23 CN CN2006800141431A patent/CN101166706B/zh not_active Expired - Fee Related
- 2006-02-23 EP EP11008995A patent/EP2418191A1/en not_active Withdrawn
- 2006-02-23 US US11/816,625 patent/US7893304B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20090036542A1 (en) | 2009-02-05 |
JP5150807B2 (ja) | 2013-02-27 |
WO2006093014A1 (ja) | 2006-09-08 |
CA2599331A1 (en) | 2006-09-08 |
US7893304B2 (en) | 2011-02-22 |
JPWO2006093014A1 (ja) | 2008-08-07 |
EP1854777A4 (en) | 2010-07-07 |
EP1854777A1 (en) | 2007-11-14 |
KR101270841B1 (ko) | 2013-06-05 |
KR20070110391A (ko) | 2007-11-16 |
EP2418191A1 (en) | 2012-02-15 |
CN101166706B (zh) | 2011-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101166706B (zh) | 氢醌长链衍生物和/或苯氧基长链衍生物及含有它们的药品 | |
JP2005536554A (ja) | 新規なビフェニル及びビフェニル様カンナビノイド | |
EP1076653B1 (en) | Novel cannabinoids selective for the cb2 receptor | |
FR2903107A1 (fr) | Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique | |
JP2008515978A (ja) | カンナビネルジック脂質リガンド | |
EP3409658B1 (en) | Tetrahydronaphthalene derivative | |
FR2928149A1 (fr) | Composes derives d'azetidines, leur preparation et leur application en therapeutique | |
WO2007119001A2 (fr) | Derives d 'aminomethyl pyridine, leur preparation et leur application en therapeutique | |
EP2212305A1 (en) | Beta-lactone compounds | |
EP1899298B1 (fr) | Derives de 4,5-diarylpyrrole, leur preparation et leur application en therapeutique | |
JPH11509848A (ja) | N−(4−置換−ベンジル)−2−アミノラクタム誘導体 | |
Kigoshi et al. | Turbotoxins A and B, novel diiodotyramine derivatives from the Japanese gastropod Turbo marmorata | |
FR2908766A1 (fr) | Derives de pyrrole,leur preparation et leur utilisation en therapeutique. | |
EP1878723B1 (fr) | Dérivés de N-[(1,5-diphényl-1H-pyrazol-3-yl)méthyl]sulfonamide antagonistes des récepteurs CB1 des cannabinoïdes | |
KR102585191B1 (ko) | 신규한 벤조디아제핀-3-온 유도체 및 이를 포함하는 당뇨병성 신경병증 치료 또는 예방용 약학적 조성물 | |
KR20030086601A (ko) | 비누클레오시드 역전사효소 억제제로서의사이클로프로파헤테로사이클 | |
JPWO2010053165A1 (ja) | ビタミンd3ラクタム誘導体 | |
FR2930939A1 (fr) | Derives de pyrrole, leur preparation et leur application en therapeutique | |
JP2018537526A (ja) | ボルテゾミブ複合体及びその使用方法 | |
KR20200118158A (ko) | 신경퇴행성 질환의 치료약물 및 그의 응용 | |
JP2020514249A (ja) | レスベラトロールのシリル化誘導体および神経変性疾患、神経疾患、または炎症性疾患におけるその使用 | |
KR101881115B1 (ko) | 신규 2-치환된 테트라하이드로피란 또는 2-치환된 테트라하이드로퓨란 유도체 화합물, 이의 제조방법 및 이의 용도 | |
EP1988087A1 (en) | Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of autoimmune diseases | |
WO2019154196A1 (zh) | 用于防治神经退行性疾病的新化合物及其应用 | |
US20100035929A1 (en) | Unnatural dispyrin analogues, preparation and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: MEIJI KK Free format text: FORMER NAME: MEIJI DAIRIES CORPORATION |
|
CP01 | Change in the name or title of a patent holder |
Address after: Tokyo, Japan Patentee after: Meiji Co., Ltd. Address before: Tokyo, Japan Patentee before: Meiji Dairies Corporation |
|
ASS | Succession or assignment of patent right |
Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UNIV Effective date: 20130305 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130305 Address after: Tokyo, Japan Patentee after: Meiji Co., Ltd. Patentee after: National Center for scientific research Patentee after: Univerisity of Strasbourg Address before: Tokyo, Japan Patentee before: Meiji Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110824 Termination date: 20150223 |
|
EXPY | Termination of patent right or utility model |